Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORD62 is a non-coding RNA of the C/D box snoRNA class, primarily known as a guide RNA for site-specific 2’-O-methylation of target RNAs, particularly the 18S ribosomal RNA at residue A590[1]. It is localized in the nucleolus of eukaryotic cells and is typically found within introns of host genes. SNORD62 exists as two paralogous copies (SNORD62A and SNORD62B) in the human genome. Like other C/D box snoRNAs, it contains conserved C box (UGAUGA) and D box (CUGA) sequence motifs essential for its function and interaction with canonical protein partners in the small nucleolar ribonucleoprotein complex (snoRNP). There is no evidence that it is a therapeutic target or that it directly interacts with any drugs or acts as a clinical biomarker at this time[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORD62 (SNORD62).